Detailed Methods are available as an online-only Data Supplement. Calcifying MVs were isolated from macrophages via ultracentrifugation 7 and characterized comprehensively using histological, biochemical, and imaging techniques. To address the mechanisms for the mineralization of macrophage-derived MVs, we examined the contribution of S100A9 in gain-of-function and loss-of-function studies.
A rterial microcalcification in the thin cap overlying the necrotic core in the intima of atherosclerotic plaques may cause compliance mismatch, increase local stress, and promote microfractures, leading to plaque rupture causing acute cardiovascular events. 1, 2 Atherosclerotic plaques containing spotty calcifications consisting of calcified vesicles (precursors to microcalcification) have increased stress, thus making them more susceptible to rupture. 3 Patients with chronic renal disease (CRD) have heightened susceptibility to atherosclerosis, a greater risk of intimal and medial calcification, and a high cardiovascular mortality. 4, 5 The added complication of hyperphosphatemia may trigger the release of matrix vesicles (MVs). 6, 7 Cells release MVs to initiate mineralization in both nonpathological 8 and pathological conditions. [6] [7] [8] [9] Smooth muscle cell (SMC)-derived MVs contribute to medial calcification in patients with CRD. 7 Our molecular imaging studies colocalized early stages of atherosclerotic intimal calcification/microcalcification with macrophages. 10 During this initial phase of calcification, coincident inflammation and microcalcification suggest a direct role for macrophages in calcification. 11 In addition to the currently prevailing concept of osteogenic transition of SMCs, we hypothesized an alternative inflammation-related pathway of arterial calcification in which macrophages release microcalcification-generating MVs.
Results

MVs Released From Macrophages Contribute to Intimal Microcalcification
Immunohistochemical analysis of macrophages and SMCs (α-smooth muscle actin) in 136 human carotid endarterectomy samples and mouse arteries demonstrated that abundant macrophages associate with regions of MVs ( Figure 1A ) to a greater extent than α-smooth muscle actin-positive or Figure  1D ) with CRD, induced by 5/6 nephrectomy. 5 We used transmission electron microscopy to characterize MVs within plaques. Immunogold labeling visualized the release of CD68-positive MVs from macrophages ( Figure 1E ). MVs abound in human and mouse plaques and associate with cholesterol crystals ( Figure 1F and 1G) . Plaque areas rich in MVs showed microcalcification and dense hydroxyapatite crystals localized on the membranes of calcifying MVs ( Figure 1H ). protrusions ( Figure 2A ; provided in Online Movies) and calcium influx after Ca/P stimulation ( Figure 2B and 2C). Ca/P-stimulated macrophages released MVs (Mac-MVs) capable of mineralization, with increased calcium content ( Figure 2D and 2E), alkaline phosphatase activity (Online Figure VI) , and suggested aggregation potential ( Figure 2F and 2G). Transmission electron microscopy of MVs released by control macrophages in vitro identified membrane-bound vesicles 30 to 300 nm, showing hydroxyapatite nucleation on the membrane and inside the vesicles after Ca/P stimulation ( Figure 2H ). Mac-MVs possessed exosomal markers ( Figure  2I ) and were smaller than those described for apoptotic bodies. In addition, Ca/P stimulation did not affect the viability or apoptotic levels of mouse macrophages (Online Figure VII) . Mouse macrophages stimulated with Ca/P possessed higher levels of mRNA encoding inducible nitric oxide synthase and interleukin-6 ( Figure 2J ), markers in mice of a proinflammatory M1 macrophage polarization, whereas M2 markers tended to decrease.
Proinflammatory Macrophages Release Microcalcification-Generating MVs
Phosphatidylserine-S100A9-Annexin V Complex Facilitates MV Mineralization
Annexins contribute to SMCs and osteoblast-derived MVmediated calcification.
6,7,12 S100A9/MRP-14-positive MVs were identified in calcified plaques. 13 Calcified plaques of CRD apoE −/− mice showed expression of both S100A9 and annexin V (Anx5; Figure 3A ; Online Figure VIII) . In addition, S100A9 and Anx5 colocalized with MVs in calcified regions of human atheroma (immunogold transmission electron microscopy; Figure 3B and 3C). Ca/P stimulation enriched S100A9 and Anx5 expression in mouse Mac-MVs ( Figure 3D ). We hypothesized that S100A9 and Anx5 form a complex in Mac-MVs, similar to the complex formation of S100A9 and annexin VI.
14 The colocalization and coimmunoprecipitation analysis of S100A9 and Anx5 in cultured mouse macrophages supported this conjecture ( Figure 3E and 3F). Ca/P stimulation of mouse macrophages augmented the association between S100A9 and Anx5 ( Figure 3F ). Anx5 and phosphatidylserine (PS) are critical for growth plate MV mineral nucleation, 15 but whether nucleation occurs inside or outside the vesicle is unclear. Ca/P-stimulated macrophages externalized PS, suggesting that nucleation may take place on the outer Mac-MV membrane ( Figure 3G ).
S100A9 as a Mediator of Mineralization
The addition of S100A9 in vitro enhanced the calcific potential of Mac-MVs ( Figure 4A ). S100A9 small interfering RNA treatment in human macrophages (Online Figure IX for silencing efficacy) limited the calcific potential of MacMVs ( Figure 4B ). To furnish further evidence in vivo for the function of S100A9 as a mediator of the calcific potential of Mac-MVs, we performed experiments using S100A9 −/− apoE −/− mice. The level of MVs quantified in mouse plasma of fat-fed apoE −/− mice trended higher than in fat-fed wild-type mice but did not achieve statistical significance with the number of animals studied. Inactivation of the S100A9 gene in apoE −/− mice tended to decrease MVs in plasma to the levels in wild-type mice ( Figure 4C ). In addition, Ca/P-stimulated S100A9 −/− mouse peritoneal macrophages released MacMVs with lower calcific potential than those isolated from wild-type mice ( Figure 4D ).
Discussion
We report a novel pathway of microcalcification that involves macrophage-derived MVs. Concentrations of extracellular Ca and P, similar to those found in serum of CRD patients on dialysis, induced the release of Mac-MVs with higher calcification potential. These findings support the operation of a new additional mechanism of arterial calcification that likely accelerates the excessive intimal and medial calcification associated with CRD. Because of the relative abundance of macrophages over SMCs in rupture-prone plaques, 1 we hypothesize that macrophage-derived MVs participate in the initiation of microcalcification.
Mac-MVs were similar to previously reported chondrocyte-derived MVs (eg, PS and Anx5 expression) 12 and exosomes (CD9 and TSG101). Mineralization of growth plate chondrocytes by MVs requires PS and Anx5; indeed, other annexins may compensate for the loss of Anx5. 15 This study found increased S100A9 and Anx5 expression in calcifying Mac-MVs, highlighting their potential importance in MV calcification. The results provide evidence that S100A9 interacts with Anx5, forming a PS-Anx5-S100A9 membrane complex, which acts as a nucleation site for hydroxyapatite ( Figure 4E ).
The use of compound mutant mice, in addition to gain-offunction and loss-of-function in vitro experiments, permitted dissection of the role of S100A9 in the calcification of macrophage-derived MVs in vivo. Previous studies identified S100A9-positive macrophages in early atherosclerotic lesions and suggested the role of this calcium-binding protein in vascular inflammation. 16 The present evidence implicates S100A9 in the mineralization of macrophage-derived MVs.
This study provides new insight into the pathogenesis of vascular calcification, particularly microcalcification, a contributor to the acute thrombotic complications of atherosclerosis. Despite its clinical challenge, we currently lack treatments and diagnostic tools to prevent or reverse cardiovascular calcification. Molecular imaging provided a novel technique for visualizing calcifying vesicular structures that could be translated to the clinic. The evidence provided should help develop therapies for this unmet medical need, including valvular and vascular calcification. Specifically, modulation of expression or function of S100A9 and Anx5 may suppress the nucleation of hydroxyapatite by macrophage-derived MVs and the generation of microcalcification in spotty plaques prone to rupture, thus preventing the onset of devastating clinical complications. mice tended to release MVs with a lower calcific potential compared with WT mice (n=9). E, Proposed mechanism: stimulated macrophages release MVs with a phosphatidylserine (PS)-annexin V (Anx5)-S100A9 complex that facilitates the nucleation of hydroxyapatite (HA) and generation of microcalcification. CRD indicates chronic renal disease; HFD, high-fat diet; and ns, not significant.
